Ventricular fibrillation following eyeball pressure in a case of paroxysmal supraventricular tachycardia

1952 ◽  
Vol 43 (5) ◽  
pp. 791-795 ◽  
Author(s):  
Milton E. Landman ◽  
Irving Ehrenfeld
Keyword(s):  
Ventricular Fibrillation ◽  
Supraventricular Tachycardia ◽  
Paroxysmal Supraventricular Tachycardia

scholarly journals Adenosine-induced ventricular fibrillation in a patient with supraventricular tachycardia

2021 ◽  
Vol 2021 (3) ◽  
Author(s):  
Shu Yu Lee ◽  
Sohil Pothiawala ◽  
Chong Meng Seet
Keyword(s):  
Ventricular Fibrillation ◽  
Supraventricular Tachycardia ◽  
Accessory Pathway ◽  
Structural Heart Disease ◽  
Paroxysmal Supraventricular Tachycardia ◽  
Frequent Use ◽  
First Case ◽  
Raising Awareness ◽  
Life Threatening ◽  
Prolonged Qt Syndrome

Adenosine is frequently used for paroxysmal supraventricular tachycardia (PSVT) treatment in the emergency department (ED). Atrial and ventricular pro-arrhythmic effects of adenosine were described in the literature, but ventricular fibrillation (VF) secondary to adenosine administration was rarely reported (with an incidence of < 1%). Reported herein is the first case of a 72-year-old female patient who developed VF hemodynamic collapse after an intravenous administration of adenosine for PSVT treatment. She had no known pre-excitation or accessory pathway, nor any underlying structural heart disease or prolonged QT syndrome. Raising awareness of this potential life-threatening pro-arrhythmic effect of adenosine is important, given its frequent use for PSVT treatment in the ED.

Effects of oral diltiazem in paroxysmal supraventricular tachycardia

1983 ◽  
Vol 52 (3) ◽  
pp. 271-278 ◽  
Author(s):  
San-Jou Yeh ◽  
Hwai-Cheng Kou ◽  
Fun-Chung Lin ◽  
Jui-Sung Hung ◽  
Delon Wu
Keyword(s):  
Supraventricular Tachycardia ◽  
Paroxysmal Supraventricular Tachycardia
Sign in / Sign up

Export Citation Format

Share Document